These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


661 related items for PubMed ID: 17206080

  • 1. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña S.
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [Abstract] [Full Text] [Related]

  • 2. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L, Lakatos PL, Willheim-Polli C, Reinisch W, Ferenci P, Tulassay Z, Molnár T, Kovács A, Papp J, Szalay F, Hungarian IBD Study Group.
    Orv Hetil; 2004 Jul 04; 145(27):1403-11. PubMed ID: 15320482
    [Abstract] [Full Text] [Related]

  • 3. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB.
    Eur J Gastroenterol Hepatol; 2007 Mar 04; 19(3):217-23. PubMed ID: 17301648
    [Abstract] [Full Text] [Related]

  • 4. [Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery].
    Nascimbeni R, Di Fabio F, Lanzini A, Lanzarotto F, Ricci C, Casella C, Salerni B.
    Ann Ital Chir; 2009 Mar 04; 80(4):293-8. PubMed ID: 19967888
    [Abstract] [Full Text] [Related]

  • 5. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW.
    Eur J Gastroenterol Hepatol; 2007 Jun 04; 19(6):449-59. PubMed ID: 17489054
    [Abstract] [Full Text] [Related]

  • 6. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A.
    Am J Gastroenterol; 2005 Jan 04; 100(1):84-92. PubMed ID: 15654786
    [Abstract] [Full Text] [Related]

  • 7. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
    Ernst A, Jacobsen B, Østergaard M, Okkels H, Andersen V, Dagiliene E, Pedersen IS, Thorsgaard N, Drewes AM, Krarup HB.
    Scand J Gastroenterol; 2007 Dec 04; 42(12):1445-51. PubMed ID: 17852840
    [Abstract] [Full Text] [Related]

  • 8. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffin B.
    Eur J Gastroenterol Hepatol; 2008 Aug 04; 20(8):748-55. PubMed ID: 18617779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Piu J, Reverter JC, Pique JM, Yagüe J, Panés J.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):429-40. PubMed ID: 17269998
    [Abstract] [Full Text] [Related]

  • 11. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, Herrmann K, Hofbauer K, Dambacher J, Tillack C, Sackmann M, Göke B, Lohse P, Ochsenkühn T.
    Scand J Gastroenterol; 2006 Dec 15; 41(12):1421-32. PubMed ID: 17101573
    [Abstract] [Full Text] [Related]

  • 12. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population.
    Núñez C, Barreiro M, Domínguez-Muñoz JE, Lorenzo A, Zapata C, Peña AS.
    Am J Gastroenterol; 2004 Mar 15; 99(3):450-6. PubMed ID: 15056084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR, Wang MH, Rawsthorne P, Sargent M, Datta LW, Nouvet F, Shugart YY, Bernstein CN.
    Am J Gastroenterol; 2007 Feb 15; 102(2):313-23. PubMed ID: 17100976
    [Abstract] [Full Text] [Related]

  • 15. The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean area.
    Renda MC, Orlando A, Civitavecchia G, Criscuoli V, Maggio A, Mocciaro F, Rossi F, Scimeca D, Modesto I, Oliva L, Cottone M.
    Am J Gastroenterol; 2008 Mar 15; 103(3):649-55. PubMed ID: 18341489
    [Abstract] [Full Text] [Related]

  • 16. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH.
    Dig Liver Dis; 2006 Nov 15; 38(11):834-45. PubMed ID: 16920047
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of association between precolectomy thrombocytosis and the occurrence of inflammatory pouch disorders.
    Lian L, Fazio VW, Lavery IC, Hammel J, Remzi FH, Shen B.
    Dis Colon Rectum; 2009 Nov 15; 52(11):1912-8. PubMed ID: 19966641
    [Abstract] [Full Text] [Related]

  • 18. Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.
    Lakatos PL, Szalay F, Tulassay Z, Molnar T, Kovacs A, Gasztonyi B, Papp J, Lakatos L, Hungarian IBD Study Group.
    Hepatogastroenterology; 2005 Nov 15; 52(63):817-22. PubMed ID: 15966211
    [Abstract] [Full Text] [Related]

  • 19. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 20. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK, Stokkers PC, van Bodegraven AA, van Hogezand RA, Verspaget HW, de Jong DJ, van der Woude CJ, Oldenburg B, Linskens RK, Festen EA, van der Steege G, Hommes DW, Crusius JB, Wijmenga C, Nolte IM, Dijkstra G, Dutch Initiative on Crohn and Colitis (ICC).
    Gut; 2009 Mar 01; 58(3):388-95. PubMed ID: 18824555
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.